Why this matters — Three distinct ORTEX data signals have converged on BYND simultaneously. Cost to borrow spiked, utilisation hit 100%, and options sentiment turned sharply bullish — all within the same short window.
Cost to Borrow — BYND's borrow cost spiked to 64.6% on April 22nd. That was a 133% jump in one week. It has since pulled back to 38.5% (April 24th), but remains 39% above its one-month average. The sharp move signals lenders repricing risk as available supply tightens.
Utilisation — Utilisation hit 100% on April 22nd, matching the 52-week high. It sat at 99.99% the following day before easing to 90.7% on April 24th. Persistent readings above 90% throughout April indicate the borrow market is structurally constrained, not episodically tight.
Options Sentiment — The put/call ratio fell to 0.38 on April 24th. That is 1.7 standard deviations below its 20-day mean of 0.42. The ratio has trended lower all month. Call buyers are dominating options flow despite — or because of — the heavy short positioning.
Analysts are bearish. The consensus is Sell. BMO Capital cut its target to $1.00 from $4.00 on April 6th. Barclays lowered its target to $0.50 from $1.00 on April 2nd. Both maintained their negative ratings. Insider activity reinforces the cautious tone. The CFO sold 419,042 shares on April 13th. Multiple C-suite officers sold in late March. Net insider selling totalled approximately $307K over the past 90 days. BlackRock added 22.2M shares as of March 31st. Vanguard added 19.7M shares over the same period — notable passive accumulation at sub-$1 prices.
BYND has spent much of March and April with utilisation at or near 100%. The current CTB spike is not unprecedented — but the simultaneous drop in PCR alongside full utilisation is a less common combination for this name.
See the live data behind this article on ORTEX.
Open BYND on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.